EAT is up +49.38%% since April’24 pick View All Top Buy Picks
$17.10
+1.72 (+11.18%)
At Close: Jun 26, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Greenwich LifeSciences, Inc. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 98.13. In total, the insiders bought 1 142 964 and sold 271 338 GLSI shares in the last 100 trades.

Insider Power

(Last 100 transactions) 		98.13
Buy 1 142 964 Shares
Sell 271 338 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 13, 2024 Common Stock Buy Patel Snehal 174 825
Apr 01, 2024 Common Stock Buy Patel Snehal 3 000
Mar 22, 2024 Common Stock Buy Patel Snehal 2 500
Mar 20, 2024 Common Stock Buy Patel Snehal 1 500
Mar 05, 2024 Common Stock Buy Patel Snehal 30 500
Mar 04, 2024 Common Stock Buy Patel Snehal 4 100
Feb 16, 2024 Common Stock Buy Patel Snehal 10 800
Feb 15, 2024 Common Stock Buy Patel Snehal 12 700
Nov 10, 2023 Common Stock Buy Patel Snehal 5 000
Nov 03, 2023 Common Stock Buy Patel Snehal 3 500
Oct 27, 2023 Common Stock Buy Thompson Jaye 500
Oct 26, 2023 Common Stock Buy Patel Snehal 2 500
Oct 25, 2023 Common Stock Buy Patel Snehal 2 500
Oct 10, 2023 Common Stock Buy Patel Snehal 1 000
Oct 04, 2023 Common Stock Buy Patel Snehal 2 000
Sep 26, 2023 Common Stock Buy Thompson Jaye 600
Sep 19, 2023 Common Stock Buy Patel Snehal 4 000
Sep 11, 2023 Common Stock Buy Patel Snehal 1 000
Aug 22, 2023 Common Stock Buy Patel Snehal 1 000
Aug 04, 2023 Common Stock Buy Patel Snehal 2 000
Jul 21, 2023 Common Stock Buy Patel Snehal 1 000
Jul 13, 2023 Common Stock Buy Thompson Jaye 250
May 17, 2023 Common Stock Buy Patel Snehal 1 000
Apr 28, 2023 Common Stock Buy Thompson Jaye 250
Apr 19, 2023 Common Stock Buy Patel Snehal 7 000
Click to get the best stock tips daily for free!

About Greenwich LifeSciences, Inc.

Greenwich LifeSciences. Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name t... GLSI Profile

Golden Star

Ticker Date Change Price
EVBG Jun 21 0.0863% $34.76
DDOG Jun 21 1.33% $117.57
BRK-A Jun 20 0.575% $617,249.90
EPD Jun 18 2.90% $28.30
USFD Jun 18 4.33% $53.14
INTC Jun 18 0.359% $30.63
UFPT Jun 18 2.05% $253.79
^DJI Jun 18 0.714% 38,834.86 points
RGA Jun 17 1.53% $203.90
MA Jun 17 1.68% $448.11
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT